CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
2022 · Cancer · 39 citations
https://doi.org/10.1002/cncr.34582
A
Adelyn Bolithon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
104
Papers
119
Citations
6
h-index
5
i10-index
Adelyn Bolithon is an academic researcher from Cancer Institute of New South Wales. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Virus-based gene therapy research. The author has an h-index of 6, co-authored 89 publications.
ORCID: 0000-0003-1914-6125Papers by this author
worksGene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
2022 · Clinical Cancer Research · 19 citations
https://doi.org/10.1158/1078-0432.ccr-22-1206
Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis
2025 · Gynecologic Oncology · 2 citations
https://doi.org/10.1016/j.ygyno.2025.05.013
Figure 1 from Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.26711139.v1
Figure 2 from Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.26711136
Figure 3 from Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.26711133
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat